Effect of antifibrotic therapy in patients with idiopathic pulmonary fibrosis undergoing lung transplant in the peri and post-operative period.
Sign Up to like & getrecommendations! Published in 2021 at "Respiratory medicine"
DOI: 10.1016/j.rmed.2021.106599
Abstract: BACKGROUND Idiopathic pulmonary fibrosis (IPF) is a rapidly progressive interstitial lung disease with high mortality. Lung transplant remains a cornerstone of treatment despite the advent of antifibrotic therapy. In light of the increasing number of… read more here.
Keywords: therapy; lung transplant; period; antifibrotic therapy ... See more keywords
The extended utility of antifibrotic therapy in progressive fibrosing interstitial lung disease
Sign Up to like & getrecommendations! Published in 2020 at "Expert Review of Respiratory Medicine"
DOI: 10.1080/17476348.2020.1784730
Abstract: ABSTRACT Introduction The approval of two antifibrotic treatment agents for delaying disease progression in idiopathic pulmonary fibrosis (IPF), has prompted researchers to look at expanding the role of antifibrotic therapy to other fibrosing interstitial lung… read more here.
Keywords: fibrosing interstitial; disease; interstitial lung; therapy ... See more keywords
Effect of Antifibrotic Therapy on Survival in Patients With Idiopathic Pulmonary Fibrosis.
Sign Up to like & getrecommendations! Published in 2022 at "Clinical therapeutics"
DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2427
Abstract: PURPOSE Real-world studies have reported reduced mortality in patients with idiopathic pulmonary fibrosis (IPF) treated with antifibrotic therapy; however, the initiation or discontinuation of therapy during these studies may have introduced bias. This study investigated… read more here.
Keywords: patients idiopathic; antifibrotic therapy; methodology; effect antifibrotic ... See more keywords